• 1
    U.S. department of health and human services. 2004 annual report of the U.S. organ procurement and transplantation network and the scientific registry of transplant recipients: Transplant data 1994–2003.
  • 2
    Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333336.
  • 3
    Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Cadaveric versus living-donor livers: Differences in inflammatory markers after transplantation. Transplantation 2003; 76: 15991603.
  • 4
    Van Der Hoeven JA, Moshage H, Schuurs T, Nijboer M, Van Schilfgaarde R, Ploeg RJ. Brain death induces apoptosis in donor liver of the rat. Transplantation 2003; 76: 11501154.
  • 5
    Colombo G, Gatti S, Turcatti F et al. Alteration in the transcriptional profile of livers from brain-dead organ donors. Transplantation 2006; 82: 6979.
  • 6
    Koning OH, Ploeg RJ, Van Bockel JH et al. Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997; 63: 16201628.
  • 7
    Gatti S, Colombo G, Turcatti F et al. Reduced expression of the melanocortin-1 receptor in human liver during brain death. Neuroimmunomodulation 2006; 13: 5155.
  • 8
    Audibert G, Charpentier C, Seguin-Devaux C et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation 2006; 82: 10311036.
  • 9
    Boom H, Mallat MJ, De Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859866.
  • 10
    Bundesärztekammer. Richtlinien zur feststellung des hirntodes. Deutsches Ärzteblatt 1998; 95: 18611864.
  • 11
    Mertes PM. Physiology of brain death. In: TilneyNL, StormTB, PaulLC (eds). Transplantation biology: Cellular and molecular aspects. Philadelphia : Lippincott, 1996: 275.
  • 12
    Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997; 29: 37703772.
  • 13
    Power BM, Van Heerden PV. The physiological changes associated with brain death - current concepts and implications for treatment of the brain dead donor. Anaesth Intensive Care 1995; 23: 2636.
  • 14
    Novitzky D, Cooper D, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodthyronine therapy. Transplantation 1988; 45: 3236.
  • 15
    Bruinsma GJ, Nederhoff MG, Geertman HJ et al. Acute increase of myocardial workload, hemodynamic instability and myocardial histological changes induced by brain death in the cat. J Surg Res 1997; 68: 715.
  • 16
    Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: The role of brain death in donor lung injury. Transplantation 2003; 75: 19281933.
  • 17
    Van Der Hoeven JA, Ploeg RJ, Postema F et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: A model to study marginal organ donors. Transplantation 1999; 68: 1884.
  • 18
    Takada M, Nadeau KC, Hancock WW et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65: 15331542.
  • 19
    Kusaka M, Pratschke J, Wilhelm MJ et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405410.
  • 20
    Van Der Hoeven JA, Ter Horst GJ, Molema G et al. Effects of brain death and hemodynamic status on function and immunological activation of the potential donor liver in the rat. Ann Surg 2000; 232: 804813.
  • 21
    Wilhelm MJ, Pratschke J, Beato F et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000; 102: 24262433.
  • 22
    Pratschke J, Wilhelm MJ, Kusaka M et al. Accelerated rejection of rat renal allografts from brain-dead donors. Ann Surg 2000; 232: 263271.
  • 23
    Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138146.
  • 24
    Dallman MJ, Wood KJ, Hamano K et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993; 133: 518.
  • 25
    Kusaka S, Grailer AP, Fechner JH Jr, Burlingham WJ. Evidence for a possible Th2 bias in human renal transplant tolerance. Transplant Proc 1995; 27: 225.
  • 26
    Pratschke J, Wilhelm MJ, Kusaka M et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999; 67: 343348.
  • 27
    Koo DD, Welsh KI, McLaren AJ, Roake JA, Morris PJ, Fuggle SV. Cadaver versus living donor kidneys: Impact of donor factors on antigen induction before transplantation. Kidney Int 1999; 56: 15511559.
  • 28
    Kotsch K, Mashreghi MF, Bold G et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 2004, 77: 18661875.
  • 29
    Glanemann M, Eipel C, Nussler AK, Vollmar B, Neuhaus P. Hyperperfusion syndrome in small-for-size livers. Eur Surg Res 2005; 37: 335341.
  • 30
    Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: Definition, mechanisms of disease and clinical implications. Am J Transplant 2005; 5: 26052610.
  • 31
    Kiuchi T, Kasahara M, Uryuhara K et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999; 67: 321327.
  • 32
    Pratschke J, Kofla G, Wilhelm MJ et al. Improvements in early behavior of rat kidney allografts after treatment of the brain dead donor. Ann Surg 2001; 234: 732740.
  • 33
    Van Der Hoeven JA, Lindell S, Van Schilfgaarde R et al. Donor brain death reduces survival after transplantation in rat livers preserved for 20 hours. Transplantation 2001; 72: 16321636.
  • 34
    Amado JA, Lopez-Espadas F, Vazquez-Barquero A et al. Blood levels of cytokines in brain dead patients: Relationship with circulating hormones and acute phase reactants. Metabolism 1995; 44: 812816.
  • 35
    Kim YS, Lim CS, Kim S et al. Cadaveric renal allograft at the time of implantation has the similar immunological features with the rejecting allograft. Transplantation 2000; 70: 10801085.
  • 36
    Schwarz C, Regele H, Steininger R, Hansmann C, Mayer G, Oberbauer R. The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation 2001; 71: 16661670.
  • 37
    Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living donor livers before transplant. Transplantation 2003; 75: 20012007.
  • 38
    Jassem W, Koo DD, Muiesan P et al. Non-heart-beating versus cadaveric and living donor livers: Differences in inflammatory markers before transplantation. Transplantation 2003; 75: 13861390.
  • 39
    Okamoto S, Corso CO, Leiderer R et al. Role of hypotension in brain-death associated impairment of liver microcirculation and viability. Transpl Int 2000; 13: 428435.
  • 40
    Fuggle SV, Koo DD. Cell adhesion molecules in clinical renal transplantation. Transplantation 1998; 65: 763769.
  • 41
    Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia: Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3. Am J Pathol 1993; 142: 481488.
  • 42
    Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003; 9: 125134.
  • 43
    Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853859.
  • 44
    Dulaney R, Woerner J, Macaluso A, Hiltz M, Catania A, Lipton JM. Changes in peripheral inflammation induced by CNS actions of an α-MSH analog and of endogenous pyrogen. Prog Neuroendocrinommunol 1992; 5: 179186.
  • 45
    Choi AM, Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15: 919.
  • 46
    Maines MD. Heme oxygenase: Function, multiplicity, regulatory mechanisms and clinical applications. FASEB J 1988; 2: 25572568.
  • 47
    Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 51754.
  • 48
    Lopau K, Mark J, Schramm L, Heidbreder E, Wanner C. Hormonal changes in brain death and immune activation in the donor. Transplant Int 2000; 13 Suppl 1: S282S285.
  • 49
    Woiciechowsky C, Asadullah K, Nestler D et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998; 4: 808813.
  • 50
    Novitzky D, Rhodin J, Cooper DK, Ye Y, Min KW, DeBault L. Ultrastructure changes associated with brain death in the human donor heart. Transplant Int 1997; 10: 2432.
  • 51
    Mertes PM, Carteaux JP, Jaboin Y et al. Estimation of myocardial interstitial norepinephrine release after brain death using cardiac microdialysis. Transplantation 1994; 57: 371377.
  • 52
    Plenz G, Eschert H, Erren M et al. The interleukin-6/interleukin-6-receptor system is activated in donor hearts. J Am Coll Card 2002; 39: 15081512.
  • 53
    Birks EJ, Burton PB, Owen V et al. Elevated tumor necrosis factor-α and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 2000; 102 19 Suppl III: 352358.
  • 54
    Birks EJ, Owen VJ, Burton PB et al. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 2000; 102: 326331.
  • 55
    Lentsch AB, Ward PA. Regulation of experimental lung inflammation. Respir Physiol 2001; 128: 1721.
  • 56
    Chiu JJ, Wung BS, Shyy JY, Hsieh HJ, Wang DL. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17: 35703577.
  • 57
    Van Der Hoeven JA, Molema G, Ter Horst GJ et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 18741882.
  • 58
    Pratschke J, Wilhelm MJ, Kusaka M, Hancock WW, Tilney NL. Acute rejection of rat renal allografts is accelerated by donor brain death. Transplant Proc 1999; 31: 874875.
  • 59
    Wilhelm MJ, Pratschke J, Kusaka M, Hancock WW, Tilney NL. Donor brain death affects tempo and intensity of acute rejection of rat cardiac allografts. Transplant Proc 1999; 31: 10081009.
  • 60
    Kotsch K, Francuski M, Pascher A et al. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant 2006; 6: 477486.
  • 61
    Kuecuek O, Mantouvalou L, Klemz R et al. Significant reduction of proinflammatory cytokines by treatment of the brain dead donor. Transplant Proc 2005; 37: 387388.